Home » Drug Information
Recently Approved Drugs
The following database contains a listing of drugs approved by the Food and Drug Administration (FDA) for sale in the United States. The database is searchable by year or by medical area. Drug information typically includes the drug name, approval status, indication of use, and clinical trial results.
Find out more about the types of drugs included in this listing.
Year: 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | [1998] | 1997 | 1996 | 1995 | View By Medical Area
Agrylin; Roberts Pharmaceutical;
Treatment for Thrombocythemia, Approved December 1998
Atacand; Astra Merck;
Treatment for hypertension, Approved June 1998
Atacand (R) (candesartan cilexetil); Astra Merck;
Treatment for hypertension, Approved June 1998
CellCept; Roche;
Treatment for the prevention of organ rejection inpatients undergoing heart transplants, Approved February 1998
Diovan HCT; Novartis;
Treatment for hypertension, Approved March 1998
Integrilin; COR Therapeutics, Key Pharmaceuticals;
Injection of eptifibatide, Approved May 1998
Micardis; Boehringer Ingelheim;
Treatment for Hypertension, Approved November 1998
Rythmol; Knoll Pharmaceutical;
Treatment for paroxysmal atrial fibrillation, Approved January 1998
Tiazac; Forest Laboratories;
Treatment for chronic stable angina, Approved February 1998
Tiazac; Forest Laboratories;
Treatment for chronic stable angina, Approved February 1998
Tricor; Abbott Laboratories;
Treatment for very high triglyceride levels, Approved February 1998
Viagra; Pfizer;
Treatment for impotence, Approved March 1998
Atridox therapy; Atrix Laboratories;
Treatment for periodontal disease, Approved September 1998
Periostat; CollaGenex Pharmaceuticals;
Treatment for periodontitis., Approved October 1998
Avita Gel; Penederm;
Treatment for acne, Approved February 1998
Dynabac; Sanofi Pharmaceuticals;
Treatment for acute bacterial exacerbations (chronic bronchitis and skin infections), Approved March 1998
Lustra; Medicis Pharmaceutical;
Treatment for ultraviolet-induced skin discolorations, Approved January 1998
MetroLotion; Galderma Laboratories;
Treatment of inflammatory papules and pustules of rosacea, Approved November 1998
Noritate; Dermik Laboratories;
Treatment for rosacea, Approved January 1998
Salagen Tablets; MGI Pharma;
Treatment for Sjogren's Syndrome, Approved February 1998
Sulfamylon; Mylan Laboratories;
Treatment used to control bacterial infections on excised burn wounds, Approved June 1998
Thalomid; Celgene;
Treatment for moderate to severe erythema nodosum leprosum (ENL), Approved July 1998
Actonel; Procter & Gamble, Hoechst Marion Roussel;
Treatment for Paget's Disease, Approved April 1998
Arava; Hoechst Marion Roussel;
Treatment for Rheumatoid Arthritis, Approved September 1998
Atacand; Astra Merck;
Treatment for hypertension, Approved June 1998
Atacand (R) (candesartan cilexetil); Astra Merck;
Treatment for hypertension, Approved June 1998
Celexa; Forest Laboratories;
Treatment for depression, Approved July 1998
CellCept; Roche;
Treatment for the prevention of organ rejection inpatients undergoing heart transplants, Approved February 1998
Clomipramine hydrochloride; Mylan Laboratories;
Generic equivalent of Anafranil, Approved April 1998
Diovan HCT; Novartis;
Treatment for hypertension, Approved March 1998
Esclim; Fournier Research;
Treatment for symptoms associated to Menopause, Approved August 1998
Estratab (.3 mg ); Solvay Pharmaceuticals;
Treatment for the prevention of osteoporosis, Approved March 1998
Glucagon; Eli Lilly;
Treatment for severe hypoglycemia associated with diabetes., Approved October 1998
Glucagon; Eli Lilly;
Treatment for severe Hypoglycemia, Approved September 1998
Glyburide Tablets; Mylan Laboratories;
Treatment for Diabetes Mellitus (Type II), Approved July 1998.
Herceptin; Genentech;
Treatment for metastatic breast cancer, Approved October 1998
Inform HER-2/neu breast cancer test; Oncor;
Treatment for breast cancer prediction, Approved January 1998
Marplan Tablets; Roche;
Treatment of Depression, Approved August 1998
Mircette; Organon;
Oral contraceptive, Approved April 1998
Prempro; Wyeth-Ayerst Laboratories;
Treatment for hormone replacement therapy, Approved January 1998
Prometrium; Schering;
Treatment for Endometrial Hyperplasia, Approved December 1998
Proscar; Merck;
Treatment for complication relating to benign prostatic hyperplasia (BPH), Approved April 1998
Simulect; Novartis;
Treatment for acute organ transplant rejection, Approved May 1998
Xeloda; Roche;
Treatment for advanced breast cancer tumors, Approved April 1998
Zemplar; Abbott Laboratories;
Treatment of secondary hyperparathyroidism associated with chronic renal failure, Approved April 1998
Cimetidine; Pharmaceutical Formulations;
Generic equivalent of Tagamet HB 200, Approved June 1998
PREVACID(R) (lansopraxole); TAP Pharmaceuticals;
Treatment of heartburn associated with GERD, Approved April 1998
Prilosec; Astra Merck;
Treatment for heartburn, Approved January 1998
Zantac 75 Efferdose; GlaxoWellcome;
Treatment for heartburn, Approved March 1998
Actonel; Procter & Gamble, Hoechst Marion Roussel;
Treatment for Paget's Disease, Approved April 1998
Droxia; Bristol-Myers Squibb;
Treatment for sickle-cell anemia, Approved March 1998
Glucagon; Eli Lilly;
Treatment for severe Hypoglycemia, Approved September 1998
Lovenox; Rhone Poulenc Rorer;
Treatment for prevention of blood clots following hip-replacement surgery, Approved February 1998
Neupogen; Amgen;
Treatment for slow white blood cell recovery following chemotherapy, Approval April 1998
Refludan; Hoechst Marion Roussel;
Treatment of heparin-induced thrombocytopenia type II, Approved March 1998
Allegra-D; Hoechst Marion Roussel;
Treatment for nasal congestion due to seasonal allergy, Approved March 1998
CellCept; Roche;
Treatment for the prevention of organ rejection inpatients undergoing heart transplants, Approved February 1998
Clemastine fumarate syrup; Morton Grove Pharmaceuticals;
Generic equivalent of Tavist Syrup, Approved March 1998
Cleocin Vaginal Cream 2%; Pharmacia & Upjohn;
Treatment for bacterial vaginosis, Approved March 1998
Dynabac; Sanofi Pharmaceuticals;
Treatment for acute bacterial exacerbations (chronic bronchitis and skin infections), Approved March 1998
REBETRON (TM) Combination Therapy; Schering-Plough;
Treatment for Chronic Hepatitis C, Approved June 1998
Simulect; Novartis;
Treatment for acute organ transplant rejection, Approved May 1998
Timentin; SmithKline Beecham;
Treatment for wide range of infections in children, Approved January 1998
Viroptic; King Pharmaceuticals;
Treatment for inflammation of the cornea in children due to herpes simplex virus, Approved February 1998
Actonel; Procter & Gamble, Hoechst Marion Roussel;
Treatment for Paget's Disease, Approved April 1998
Estratab (.3 mg ); Solvay Pharmaceuticals;
Treatment for the prevention of osteoporosis, Approved March 1998
Etodolac tablets; Faulding;
Generic equivalent of Lodine 500 mg tablets, Approved May 1998
Lodine XL; Wyeth-Ayerst Laboratories;
Treatment for arthritis, Approved February 1998
Lovenox; Rhone Poulenc Rorer;
Treatment for prevention of blood clots following hip-replacement surgery, Approved February 1998
Detrol tablets; Pharmacia & Upjohn;
Treatment for an overactive bladder, Approved March 1998
Ditropan XL Tablets; Alza;
Treatment for and Overactive Bladder, Approved December 1998
Proscar; Merck;
Treatment for complication relating to benign prostatic hyperplasia (BPH), Approved April 1998
RenaGel; Geltex;
Treatment for Renal Disease, Approved November 1998
Simulect; Novartis;
Treatment for acute organ transplant rejection, Approved May 1998
Zemplar; Abbott Laboratories;
Treatment of secondary hyperparathyroidism associated with chronic renal failure, Approved April 1998
Amerge; GlaxoWellcome;
Treatment for acute migraine, Approved February 1998
Clonazepam; Watson Pharmaceuticals;
Generic equivalent of Klonopin, Approved January 1998
Cylert; Abbott Laboratories;
Treatment for Attention Deficit Disorder, Approved October 1998
Excedrin Migraine; Bristol-Myers Squibb;
Treatment for mild to moderate migraine pain, Approved January 1998
Lamictal Chewable Dispersible Tablets; GlaxoWellcome;
Treatment for Epilepsy, Approved August 1998
Maxalt; Merck;
Acute treatment of migraine headache, Approved June 1998
Naltrexone Hydrochloride Tablets; Barr Laboratories;
Generic equivalent of Revia, Approved May 1998
Oxycodone and Aspirin; Watson Pharmaceuticals;
Generic equivalent of Percodan, Approved March 1998
Tasmar; Roche;
Treatment for Parkinson's Disease, Approved January 1998
Cleocin Vaginal Cream 2%; Pharmacia & Upjohn;
Treatment for bacterial vaginosis, Approved March 1998
Esclim; Fournier Research;
Treatment for symptoms associated to Menopause, Approved August 1998
Estratab (.3 mg ); Solvay Pharmaceuticals;
Treatment for the prevention of osteoporosis, Approved March 1998
Herceptin; Genentech;
Treatment for metastatic breast cancer, Approved October 1998
Inform HER-2/neu breast cancer test; Oncor;
Treatment for breast cancer prediction, Approved January 1998
Micardis; Boehringer Ingelheim;
Treatment for Hypertension, Approved November 1998
Mircette; Organon;
Oral contraceptive, Approved April 1998
Prempro; Wyeth-Ayerst Laboratories;
Treatment for hormone replacement therapy, Approved January 1998
PREVEN ; Emergency Contraceptive Kit; Gynetics;
Emergency Contraceptive Pills, Approved September 1998
Prometrium; Schering;
Treatment for Endometrial Hyperplasia, Approved December 1998
Prometrium; Solvay Pharmaceuticals;
Treatment for amenorrhea (abnormal cessation of menses), Approved May 1998
Xeloda; Roche;
Treatment for advanced breast cancer tumors, Approved April 1998
Actiq; Anesta Corporation;
Treatment for Cancer Pain, Approved November 1998
Anzemet; Hoechst Marion Roussel;
Treatment for the prevention of nausea and vomiting associated with chemotherapy and surgery, Approved February 1998
Camptosar; Pharmacia & Upjohn;
Treatment for Colon or Rectal Cancer, Approved October 1998
Gemzar; Eli Lilly;
Treatment for Lung Cancer, Approved August 1998
Herceptin; Genentech;
Treatment for metastatic breast cancer, Approved October 1998
Inform HER-2/neu breast cancer test; Oncor;
Treatment for breast cancer prediction, Approved January 1998
Neupogen; Amgen;
Treatment for slow white blood cell recovery following chemotherapy, Approval April 1998
Nolvadex; Zeneca Pharmaceuticals;
Treatment for Breast Cancer, Approved October 1998
Photofrin; QLT;
Treatment for early-stage, microinvasive endobronchial non-small cell lung cancer, Approved January 1998
Proleukin; Chiron Corporation;
Treatment for metastatic melanoma, Approved January 1998
Sclerosol Intrapleural Aerosol; Bryan Corporation;
Treatment for malignant pleural effusions, Approved January 1998
Valstar; Anthra Pharmaceuticals;
Treatment for Bladder Cancer, Approved October 1998
Xeloda; Roche;
Treatment for advanced breast cancer tumors, Approved April 1998
Zofran; GlaxoWellcome;
Treatment for postoperative vomiting and nausea in adults, Approved April 1998
Alrex; Bausch & Lomb, Pharmos;
Treatment for seasonal allergic conjunctivitis, Approved March 1998
Cosopt; Merck;
Treatment for glaucoma or ocular hypertension, Approved April 1998
Lotemax; Bausch & Lomb, Pharmos;
Treatment for post-operative eye inflammation, Approved March 1998
Salagen Tablets; MGI Pharma;
Treatment for Sjogren's Syndrome, Approved February 1998
Viroptic; King Pharmaceuticals;
Treatment for inflammation of the cornea in children due to herpes simplex virus, Approved February 1998
Vitravene Injection; Isis Pharmaceuticals;
Treatment for CMV in AIDS patients, Approved August 1998
Rocephin; Roche;
Treatment for acute otitis media, Approved January 1998
Rocephin; Roche;
Treatment for pediatric otitis media, Approved January 1998
Curosurf; Dey Laboratories;
Treatment for respiratory distress syndrome in premature infants., Approved October 1998
Cylert; Abbott Laboratories;
Treatment for Attention Deficit Disorder, Approved October 1998
DDAVP (tablet formulation); Rhone Poulenc Rorer;
Treatment for nocturnal enuresis, Approved March 1998
Infasurf; ONY;
For the prevention and treatment of Respiratory Distress Syndrome (RDS) in premature infants, Approved July 1998.
Pulmozyme Inhalation Solution; Genentech;
Treatment for cystic fibrosis, Approved March 1998
Rocephin; Roche;
Treatment for pediatric otitis media, Approved January 1998
Rocephin; Roche;
Treatment for acute otitis media, Approved January 1998
Singulair; Merck;
Treatment for asthma, Approved February 1998
Timentin; SmithKline Beecham;
Treatment for wide range of infections in children, Approved January 1998
Viroptic; King Pharmaceuticals;
Treatment for inflammation of the cornea in children due to herpes simplex virus, Approved February 1998
Celexa; Forest Laboratories;
Treatment for depression, Approved July 1998
Clomipramine hydrochloride; Mylan Laboratories;
Generic equivalent of Anafranil, Approved April 1998
Cylert; Abbott Laboratories;
Treatment for Attention Deficit Disorder, Approved October 1998
Marplan Tablets; Roche;
Treatment of Depression, Approved August 1998
Naltrexone Hydrochloride Tablets; Barr Laboratories;
Generic equivalent of Revia, Approved May 1998
Prochlorperazine; IVAX;
Generic equivalent of SmithKline Beecham's Compazine, Approved January 1998
Allegra-D; Hoechst Marion Roussel;
Treatment for nasal congestion due to seasonal allergy, Approved March 1998
Clemastine fumarate syrup; Morton Grove Pharmaceuticals;
Generic equivalent of Tavist Syrup, Approved March 1998
Curosurf; Dey Laboratories;
Treatment for respiratory distress syndrome in premature infants., Approved October 1998
Dynabac; Sanofi Pharmaceuticals;
Treatment for acute bacterial exacerbations (chronic bronchitis and skin infections), Approved March 1998
Infasurf; ONY;
For the prevention and treatment of Respiratory Distress Syndrome (RDS) in premature infants, Approved July 1998.
Priftin; Hoechst Marion Roussel;
Treatment for pulmonary tuberculosis, Approved June 1998
Pulmozyme Inhalation Solution; Genentech;
Treatment for cystic fibrosis, Approved March 1998
Sclerosol Intrapleural Aerosol; Bryan Corporation;
Treatment for malignant pleural effusions, Approved January 1998
Singulair; Merck;
Treatment for asthma, Approved February 1998
Synagis; MedImmune;
Treatment for the prevention of serious lower respiratory tract disease in infants, Approved June 1998
Arava; Hoechst Marion Roussel;
Treatment for Rheumatoid Arthritis, Approved September 1998
Lodine XL; Wyeth-Ayerst Laboratories;
Treatment for arthritis, Approved February 1998
Salagen Tablets; MGI Pharma;
Treatment for Sjogren's Syndrome, Approved February 1998
